Contraceptive vaccines for mammals
US9649367B2 · kind B2 · utility
0Cited by
1References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 21, 2014 |
| Grant date | May 16, 2017 |
| Priority date | — |
| Expiry date | Aug 1, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/515
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a contraceptive vaccine for a female recipient of a target species of mammals including a composition of at least one of a plurality of granulosa cells and a plurality of ovarian stromal cells in combination with an adjuvant; wherein the cells are grown from a tissue sample of the cells obtained from at least one female donor of the target species which is not the same individual as the female recipient. The invention also provides a method of producing the contraceptive vaccine as well as a method of treating a female recipient with the contraceptive vaccine to prevent pregnancy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.